HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of ...

When can I get back to skiing?"That was one of the first questions 68-year-old William "Bill" Borelli asked UC Davis Health ...

Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

Medtronic has launched an agreement with Dragonfly Endoscopy to distribute its pancreaticobiliary system in the U.S. The system aims to provide enhanced visualization, maneuverability and diagnostic ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is ...

Lucknow: Experts at Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) emphasised importance of raising awareness about a ‘stool chart' as a sim.

Subtle signs of SIBO include nutritional deficiencies, rosacea, brain fog and fatigue. Meet with a health care provider to ...

Explore groundbreaking research on lab-grown liver organoids that mimic natural zonal structures for medical advancements.

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Medtronic plans to launch the system across select clinical and academic centres in the country starting this year.